Skip to main content

Table 1 Patient characteristics

From: Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial

 

SEVO (n = 30)

SEVO+ (n = 30)

p value

PROP (n = 30)

PROP+ (n = 29)

p value

Sex (female/male)

14/16

16/14

1.000

19/11

16/13

1.000

Age (years)

48 ± 16

38 ± 15

0.112

42 ± 14

41 ± 13

1.000

Body weight (kg)

80 ± 16

77 ± 18

1.000

72 ± 15

74 ± 16

1.000

Height (cm)

175 ± 12

172 ± 17

1.000

173 ± 10

172 ± 15

1.000

ASA I/II

14/16

17/13

1.000

18/12

17/12

1.000

  1. Values are expressed as mean ± standard deviation; SEVO Sevoflurane anesthesia without additional monitoring; SEVO+ Sevoflurane anesthesia with BIS and TOF monitoring; PROP Propofol anesthesia without additional monitoring; PROP+ Propofol anesthesia with BIS and TOF monitoring; ASA American Society of Anesthesiologists physical status; gender and ASA grade are the number of patients